While we initially included the distant (tumor-free) mammary gland mucosa as a TRM-free control, we found that CD8+CD103+ TRMs developed in all tissues and their frequency increased with tumor growth, even in the distant mucosa (Figure 1A). This evidence concerns the gene ITGAE and neoplasm.